Contact us

한국지사
㈜가이스트리히코리아
서울특별시 서초구
강남대로 285
(서초동, 태우빌딩 9F)
우편번호 06729
대한민국  

Phone: +82 2 553 7632
Fax: +82 02 553 7634
info@geistlich.co.kr

대표: 마티아스 둥켈 외 1인
사업자등록번호: 220-86-93505
통신판매업신고번호: 2015-서울서초-2119호
개인정보관리책임자: 장용민 (info@geistlich.co.kr)

Write us
Home / About us / News

International News

New General Manager at Geistlich Biomaterials Germany

As of 1 October 2024, Marcus Kieffer is the new General Manager of Geistlich Biomaterials in Germany. He succeeds Dr Thomas Braun, who will retire at the end of 2024 after 28 successful years.
10월 10, 2024

With 30 years of experience in the dental industry, including 20 years in national and international sales and 10 years as Managing Director of various companies, Marcus Kieffer is ideally qualified for his new role as Managing Director of Geistlich Biomaterials Germany. Most recently, as Managing Director of Ivoclar Services & Support GmbH in Germany, he successfully led the company through important change processes. “I am delighted to be joining one of the leading companies in the field of regenerative biomaterials. Geistlich is a pioneer in regenerative medicine and its innovative solutions have improved the quality of life of countless patients,” says Marcus Kieffer, “I look forward to working with our dedicated team and our partners to actively shape the future of regeneration.”

28 years in the service of medical regeneration
Geistlich thanks Dr. Thomas Braun for his significant contribution to the company over the past 28 years. Thomas Braun joined the newly founded affiliate in Baden-Baden in 1996 as Head of Marketing and Sales and built up the company locally. In this role, the molecular biologist, who holds a doctorate, launched the distribution of Geistlich Bio-Oss® and Geistlich Bio-Gide® in Germany. In 2001, he took over as managing director of Geistlich Biomaterials Germany. He enabled countless patients to access the most advanced regenerative treatments and was a pioneer for medical regeneration in Germany. 

Today, the affiliate serves one of the most important markets and the team has grown to around 40 employees. “With his high level of commitment and extensive expertise, he has made a decisive contribution to advancing medical regeneration in Germany,” says Dr. Matthias Dunkel, COO Geistlich.